Annexins and disease

被引:132
作者
Hayes, MJ [1 ]
Moss, SE [1 ]
机构
[1] Inst Ophthalmol, Div Cell Biol, London EC1V 9EL, England
关键词
annexin; cancer; cardiovascular disease; diabetes; anti-phospholipid syndrome;
D O I
10.1016/j.bbrc.2004.07.124
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The annexins are a family of closely related calcium- and membrane-binding proteins expressed in most eukaryotic. cell types. Despite their structural and biochemical similarities annexins have diverse functions, in cellular activities that include vesicle trafficking, cell division, apoptosis, calcium signalling, and growth regulation. To date there is no evidence to suggest that any individual member of the annexin family is a disease-causing gene, i.e., a gene that through loss, mutation, translocation or amplification leads to a known human disease. However, there is good evidence that in certain clinical conditions, changes in annexin expression levels or localisation may contribute to the pathological consequences and sequelae of disease. In this way, annexins are indirectly linked to some of the most serious human disease classes including cardiovascular disease and cancer. In this review we consider the roles played by annexins in disease and examine the molecular basis for anomalous annexin behaviour that may contribute to disease pathophysiology. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1166 / 1170
页数:5
相关论文
共 50 条
[1]   Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages [J].
Brownstein, C ;
Deora, AB ;
Jacovina, AI ;
Weintraub, R ;
Gertler, M ;
Khan, KMF ;
Falcone, DJ ;
Hajjar, KA .
BLOOD, 2004, 103 (01) :317-324
[2]  
Chetcuti A, 2001, CANCER RES, V61, P6331
[3]   Annexin II tetramer inhibits plasmin-dependent fibrinolysis [J].
Choi, KS ;
Ghuman, J ;
Kassam, G ;
Kang, HM ;
Fitzpatrick, SL ;
Waisman, DM .
BIOCHEMISTRY, 1998, 37 (02) :648-655
[4]   Biomarkers of human cutaneous squamous cell carcinoma from tissues and cell lines identified by DNA microarrays and qRT-PCR [J].
Dooley, TP ;
Reddy, SP ;
Wilborn, TW ;
Davis, RL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 306 (04) :1026-1036
[5]  
Emoto K, 2001, ANTICANCER RES, V21, P1339
[6]  
Francia G, 1996, CANCER RES, V56, P3855
[7]   Actin and annexins I and II are among the main endothelial plasmalemma-associated proteins forming early glucose adducts in experimental diabetes [J].
Ghitescu, LD ;
Gugliucci, A ;
Dumas, F .
DIABETES, 2001, 50 (07) :1666-1674
[8]   A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients [J].
González-Conejero, R ;
Corral, J ;
Roldán, V ;
Martínez, C ;
Marín, F ;
Rivera, J ;
Iniesta, JA ;
Lozano, ML ;
Marco, P ;
Vicente, V .
BLOOD, 2002, 100 (06) :2081-2086
[9]   Is diabetic hypercoagulability an acquired annexinopathy? Glycation of annexin II as a putative mechanism for impaired fibrinolysis in diabetic patients [J].
Gugliucci, A ;
Ghitescu, L .
MEDICAL HYPOTHESES, 2002, 59 (03) :247-251
[10]  
Han EKH, 2000, BRIT J CANCER, V83, P83